Interleukin-10 and the regulation of mitogen-activated protein kinases:: are these signalling modules targets for the anti-inflammatory action of this cytokine?

被引:56
作者
Haddad, JJ
Saadé, NE
Safieh-Garabedian, B
机构
[1] Univ Calif San Francisco, Sch Med, Dept Anesthesia & Perioperat Care, Mol Neurosci Res Div,Severinghaus Radiometer Res L, San Francisco, CA 94143 USA
[2] Amer Univ Beirut, Fac Arts & Sci, Dept Biol, Beirut 110236, Lebanon
[3] Amer Univ Beirut, Fac Med, Dept Human Morphol & Physiol, Div Mol & Behav Neurosci, Beirut 110236, Lebanon
[4] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA
基金
英国医学研究理事会; 英国惠康基金; 美国国家卫生研究院;
关键词
cell signalling; cytokine; disease; IL-10; immunopharmacology; inflammation; kinase; MAPK;
D O I
10.1016/S0898-6568(02)00075-X
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The many specific, yet overlapping and redundant activities of individual cytokines have been the basis for current concepts of therapeutical intervention. Cytokines are powerful two-edged weapons that can trigger a cascade of reactions and may show activities that often go beyond the single highly specific property that it is hoped they possess. Nevertheless, it can be stated that our new, though burgeoning, understanding of the biological mechanisms governing cytokine actions is an important contribution to medical knowledge. The crucial role of the anti-inflammatory cytokine, interleukin (IL)-10, in regulating potential molecular pathway mediating injury and cell death has attracted paramount attention in recent years. In this respect, the mitogen-activated protein kinase (MAPK) components have emerged as potential signalling cascades that regulate a plethora of cell functions, including inflammation and cell death. The biochemistry and molecular biology of cytokine actions, particularly IL-10, explain some well known and sometimes also some of the more obscure clinical aspects of the evolution of diseases. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:255 / 267
页数:13
相关论文
共 145 条
[1]   Inhibition of IL-6 and IL-10 signaling and Stat activation by inflammatory and stress pathways [J].
Ahmed, ST ;
Ivashkiv, LB .
JOURNAL OF IMMUNOLOGY, 2000, 165 (09) :5227-5237
[2]   Cytokine network and dysregulated apoptosis in atopic dermatitis [J].
Akdis, M ;
Trautmann, A ;
Klunker, S ;
Blaser, K ;
Akdis, CA .
ACTA ODONTOLOGICA SCANDINAVICA, 2001, 59 (03) :178-182
[3]   Ras activation of the Raf kinase: Tyrosine kinase recruitment of the MAP kinase cascade [J].
Avruch, J ;
Khokhlatchev, A ;
Kyriakis, JM ;
Luo, ZJ ;
Tzivion, G ;
Vavvas, D ;
Zhang, XF .
RECENT PROGRESS IN HORMONE RESEARCH, VOL 56, 2001, 56 :127-155
[4]   Tat protein of human immunodeficiency virus type 1 induces interleukin-10 in human peripheral blood monocytes: Implication of protein kinase C-dependent pathway [J].
Badou, A ;
Bennasser, Y ;
Moreau, M ;
Leclerc, C ;
Benkirane, M ;
Bahraoui, E .
JOURNAL OF VIROLOGY, 2000, 74 (22) :10551-10562
[5]   Cytokine modulators as novel therapies for asthma [J].
Barnes, PJ .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2002, 42 :81-98
[6]   The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs) [J].
Barr, RK ;
Bogoyevitch, MA .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2001, 33 (11) :1047-1063
[7]   Inflammation in the nervous system: The human perspective [J].
Bauer, J ;
Rauschka, H ;
Lassmann, H .
GLIA, 2001, 36 (02) :235-243
[8]   Diversity of G protein-coupled receptor signaling pathways to ERK/MAP kinase [J].
Belcheva, MM ;
Coscia, CJ .
NEUROSIGNALS, 2002, 11 (01) :34-44
[9]  
BHATIA M, 2001, J CURR OPIN INVESTIG, V2, P496
[10]  
Boraschi Diana, 1998, European Cytokine Network, V9, P205